Phase 3 study of Vectibix for the treatment of metastatic colorectal cancer (mCRC) - MPR
Links shared publicly online about this topic.
- 818total visits
Phase 3 study of Vectibix for the treatment of metastatic colorectal cancer (mCRC) - MPR
empr.com —
View full resource at empr.com
Tags: Cancer, Rectal Cancer, Colon Cancer, Colorectal Cancer Medication, Phase 3 Clinical Trial, Vectibix, News
Most Recently Shared on October 7, 2010 at 9:54 pm By:
MPR News: Phase 3 study of Vectibix for the treatment of metastatic colorectal cancer (mCRC): Amgen announced resu... http://bit.ly/9qpMYN
Phase 3 Study of Zaltrap for Metastatic Colorectal Cancer - ONA
oncologynurseadvisor.com — “Sanofi-aventis and Regeneron Pharmaceuticals announced positive results from the Phase 3 VELOUR study of Zaltrap (aflibercept), also known as VEGF Trap, for the second-line treatment of metastatic colorectal cancer (mCRC).” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 27, 2011 at 2:24 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Phase 3 Study of Zaltrap for Metastatic Colorectal Cancer http://goo.gl/fb/khfIz
AstraZeneca Announces Results Of Recentin HORIZON II Phase III Trial In Metastatic Colorectal Cancer
medicalnewstoday.com — “AstraZeneca announced the top-line results of the HORIZON II Phase III study evaluating RECENTIN (cediranib) for the first-line treatment of metastatic colorectal cancer (mCRC). Cediranib met the” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 4:38 pm By:
AstraZeneca Announces Results Of Recentin HORIZON II Phase III Trial In Metastatic Colorectal Cancer: AstraZeneca ... http://mnt.to/f/3DkJ
Advertisement
